Account wins

Share this article:
Centron has announced the following new agency of record assignments. Eisai has selected Centron as the advertising agency of record for their CTCL oncology portfolio, which includes ONTAK (denileukin diftitox), Targretin (bexarotene) capsules, and Targretin (bexarotene) gel 1.1%. Millennium Pharmaceuticals, has awarded Centron the advertising agency of record assignment for Velcade (bortezomib) for injection, their product for multiple myeloma and mantle cell lymphoma. Centron also announces that they have received additional assignments from Stiefel Laboratories, with agency of record assignments for Soriatane (acitretin), MimyX Cream, Olux-E (clobetasol propianate) Foam 0.05%, Verdeso (desonide) Foam, 0.05%, Olux (clobetasol propionate) Foam, 0.05%, and Luxiq (betamethasone valerate) Foam, 0.12%.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.